Soleno Therapeutics (NASDAQ: SLNO)
Q3 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-11-09 | ||||||
REV |
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.060 | ||||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Soleno Therapeutics (NASDAQ: SLNO) through any online brokerage.
Other companies in Soleno Therapeutics’s space includes: Biocept (NASDAQ:BIOC), Monopar Therapeutics (NASDAQ:MNPR), Calithera Biosciences (NASDAQ:CALA), ABVC BioPharma (NASDAQ:ABVC) and Biophytis (NASDAQ:BPTS).
The latest price target for Soleno Therapeutics (NASDAQ: SLNO) was reported by Guggenheim on Tuesday, September 29, 2020. The analyst firm set a price target for 8.00 expecting SLNO to rise to within 12 months (a possible 4341.98% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Soleno Therapeutics (NASDAQ: SLNO) is $0.1801 last updated Today at August 18, 2022, 3:40 PM UTC.
There are no upcoming dividends for Soleno Therapeutics.
Soleno Therapeutics’s Q3 earnings are confirmed for Wednesday, November 9, 2022.
There is no upcoming split for Soleno Therapeutics.
Soleno Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.